These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27508049)

  • 1. Expression of programmed death-1 ligand (PD-L1) in tumor-infiltrating lymphocytes is associated with favorable spinal chordoma prognosis.
    Zou MX; Peng AB; Lv GH; Wang XB; Li J; She XL; Jiang Y
    Am J Transl Res; 2016; 8(7):3274-87. PubMed ID: 27508049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Programmed Death-Ligand 1 of Prognostic Significance in Triple-Negative Female Mammary Carcinoma?
    Sanad AM; Ibrahim WS; Ezzo IM; Sabry RM
    J Microsc Ultrastruct; 2024; 12(1):6-13. PubMed ID: 38633572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of programmed cell death ligand 1 (PD-L1) expression and its association with epithelial-mesenchymal transition in extrahepatic cholangiocarcinoma.
    Ueno T; Tsuchikawa T; Hatanaka KC; Hatanaka Y; Mitsuhashi T; Nakanishi Y; Noji T; Nakamura T; Okamura K; Matsuno Y; Hirano S
    Oncotarget; 2018 Apr; 9(28):20034-20047. PubMed ID: 29732001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study.
    Fay AP; Signoretti S; Callea M; Telό GH; McKay RR; Song J; Carvo I; Lampron ME; Kaymakcalan MD; Poli-de-Figueiredo CE; Bellmunt J; Hodi FS; Freeman GJ; Elfiky A; Choueiri TK
    J Immunother Cancer; 2015; 3():3. PubMed ID: 25767716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion.
    Liu S; Ding G; Zhou Z; Feng C
    Onco Targets Ther; 2018; 11():2029-2036. PubMed ID: 29670378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence.
    Lopez DC; Fabian KP; Padget MR; Robbins YL; Kowalczyk JT; Lassoued W; Pastor DM; Allen CT; Gallia GL; Gulley JL; Hodge JW; London NR
    Front Oncol; 2024; 14():1376622. PubMed ID: 38741774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of Cyclin E1 Expression in Patients With Chordoma: A Clinicopathological and Immunohistochemical Study.
    Wei R; Dean DC; Thanindratarn P; Hornicek FJ; Guo W; Duan Z
    Front Oncol; 2020; 10():596330. PubMed ID: 33282745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low expression of miRNA-1290 associated with local invasion and recurrence in sacral chordoma.
    Wang Y; Chen K; Chen H; Zhang K; Lu J; Mao H; Yang H
    Int J Clin Exp Pathol; 2017; 10(11):10934-10940. PubMed ID: 31966437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
    Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
    Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Quantitative Comparison of Antibodies to Programmed Cell Death 1 Ligand 1.
    Gaule P; Smithy JW; Toki M; Rehman J; Patell-Socha F; Cougot D; Collin P; Morrill P; Neumeister V; Rimm DL
    JAMA Oncol; 2017 Feb; 3(2):256-259. PubMed ID: 27541827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of peptide inhibitors targeting human programmed death 1 (PD-1) receptor.
    Li Q; Quan L; Lyu J; He Z; Wang X; Meng J; Zhao Z; Zhu L; Liu X; Li H
    Oncotarget; 2016 Oct; 7(40):64967-64976. PubMed ID: 27533458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-1/PD-L1 Interaction Maintains Allogeneic Immune Tolerance Induced by Administration of Ultraviolet B-Irradiated Immature Dendritic Cells.
    Zhang L; Xia CQ
    J Immunol Res; 2016; 2016():2419621. PubMed ID: 27556047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors for tumor progression in patients with skull base chordoma.
    Wang L; Tian K; Wang K; Ma J; Ru X; Du J; Jia G; Zhang L; Wu Z; Zhang J
    Cancer Med; 2016 Sep; 5(9):2368-77. PubMed ID: 27546605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic implications of CD8
    Zou MX; Guo KM; Lv GH; Huang W; Li J; Wang XB; Jiang Y; She XL
    Cancer Immunol Immunother; 2018 Feb; 67(2):209-224. PubMed ID: 29051990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Immune Microenvironment of Chordomas: An Immunohistochemical Analysis.
    Dridi M; Krebs-Drouot L; Meyronet D; Dumollard JM; Vassal F; Jouanneau E; Jacquesson T; Barrey C; Grange S; Boutonnat J; Péoc'h M; Karpathiou G
    Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34283048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Impact of the Immune Microenvironment in Spinal Chordoma: Immunoscore as an Independent Favorable Prognostic Factor.
    Zou MX; Lv GH; Wang XB; Huang W; Li J; Jiang Y; She XL
    Neurosurgery; 2019 Jun; 84(6):E318-E333. PubMed ID: 30032257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for Chordoma and Chondrosarcoma: Current Evidence.
    Traylor JI; Pernik MN; Plitt AR; Lim M; Garzon-Muvdi T
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34067530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A four-factor immune risk score signature predicts the clinical outcome of patients with spinal chordoma.
    Zou MX; Pan Y; Huang W; Zhang TL; Escobar D; Wang XB; Jiang Y; She XL; Lv GH; Li J
    Clin Transl Med; 2020 Jan; 10(1):224-237. PubMed ID: 32508056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal model considerations for chordoma research: reproducing the tumor microenvironment
    Campilan B; Schroeder C; Sagaityte E; Arditi J; Leary OP; Gokaslan ZL; Sullivan PLZ; Martinez-Moreno M
    Front Oncol; 2024; 14():1330254. PubMed ID: 38544830
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.